他克莫司治疗碱烧伤致大鼠非特异性角膜炎的疗效及安全性

doi:DOI:10.3760/cma.j.issn.1674-845X.2016.01.008

摘要
图/表
参考文献(30)
相关文章 (15)

全文: PDF 9901KB HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要

目的比较他克莫司与地塞米松治疗碱烧伤所致大鼠非特异性角膜炎的疗效和安全性。方法实验研究。24只SD大鼠，体质量180~ 220 g，按随机数字表法选取20只行单眼碱烧伤造模，造模后排除2只。将18只造模成功大鼠随机分为A、B、C碱烧伤组，每组6只，A组使用PBS缓冲液作为阳性对照组（20 µl/次，3次/d），B组使用地塞米松滴眼液作为平行对照组，C组使用他克莫司滴眼液作为治疗组（20 µl/次，3次/d），D组4只为空白对照组。于碱烧伤后不同时间（1、3、5、7、10、14 d）使用裂隙灯显微镜动态观察角膜基质混浊程度、角膜新生血管面积、角膜上皮缺损面积、前房积血和角膜溃疡发生例数并记录，并取角膜组织（7、14 d各一只）进行HE染色观察角膜炎症细胞浸润和免疫组化染色检查角膜组织中血管内皮生长因子（VEGF）。应用单因素方差分析和非参数U检验对相应时间点多组或2组数据进行统计分析。结果第14天C组角膜基质较B组清晰（U=2.00，P<0.05）。B组、C组角膜新生血管面积第7、10、14天均明显较A组小（U=5.00、2.00，P<0.05；U=0.00、0.00，P<0.05；U=0.00、0.00，P<0.05），且B组、C组间差异无统计学意义。A组和C组上皮缺损面积第10、14天明显较B组小（U=0.00、0.00，P<0.05；U=0.00、0.00，P<0.05）。全程C组前房积血发生例数最少，无角膜溃疡，B组前房积血例数与A组相当且角膜溃疡最严重。第7、14天HE和免疫组织化学染色示A组角膜基质炎症细胞浸润和VEGF阳性细胞数目最多，B组、C组均较A组少（炎症细胞：U=2.00、0.00，P<0.05；U=0.00、0.00，P<0.05。VEGF阳性细胞：U=0.00、0.00，P<0.05；U=0.00、0.00，P<0.05）。第7、14天C组较B组角膜基质炎症细胞数目少（U=0.00、0.00，P<0.05），VEGF阳性细胞第7天2组差异无统计学意义，第14天C组较B组少（U=3.00，P<0.05）。结论他克莫司对碱烧伤所致大鼠非特异性角膜炎有效，且安全性优于地塞米松。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	闫应朝
	李锦阳
	陈梦曦
	徐思思
	张一威
	谷丽君

关键词 ：地塞米松, 角膜炎, 眼烧伤, 血管内皮生长因子类, 大鼠, Sprague-Dawley, 他克莫司

Abstract：

Objective To investigate the safety and efficacy of tacrolimus (FK506) and dexamethasone in the treatment of nonspecific keratitis in rats induced by alkali burn. Methods A total of 24 rats were randomly divided into four groups in this experimental study: group A (PBS, n=6), group B (dexamethasone, n=6), group C (tacrolimus, n=6) and a control group (no treatment, n=4). Biomicroscopic features, including the opacity of the corneal stroma, the area of corneal neovascularization and epithelial defect, the probability of hyphema, and the number of ulcer cases, were observed and recorded on days 1, 3, 5, 7, 10, 14 after surgery. On days 7 and 14, HE staining was done to observe corneal tissue with infiltrated inflammatory cells. An immunoreaction to vascular endothelial growth factor (VEGF) was detected. Data from multiple groups or two groups at corresponding times were analyzed using a one-way ANOVA and nonparametric Mann-Whitney U test. Results On days 14, the corneal stroma in group C was clear compared to group B (U=2.00, P<0.05). The areas of neovascularization in groups B and C on days 7, 10, and 14 were obviously smaller than the area in group A (U=5.00, 2.00, P<0.05; U=0.00, 0.00, P<0.05; U=0.00, 0.00, P<0.05). The difference between groups B and C was not statistically significant. On days 10 and 14, the areas in groups A and C with epithelial defects were obviously smaller than the area in group B (U=0.00, 0.00, P<0.05; U=0.00, 0.00, P<0.05). The possibility of hyphema in group C was the smallest and no ulcer cases were detected. The hyphema in group B was as severe as group A and many ulcer cases were detected. HE and immunohistochemical staining on days 7 and 14 revealed that the highest number of inflammatory cells infiltrating the corneal stroma and VEGF positive cells was detected in group A, followed by groups B and C (inflammatory cells, U=2.00, 0.00, P<0.05; U=0.00, 0.00, P<0.05. VEGF positive cells, U=0.00, 0.00, P<0.05; U=0.00， 0.00, P<0.05). There were fewer inflammatory cells in group C than in group B on days 7 and 14 (U=0.00, 0.00, P<0.05) and the difference in VEGF positive cells on day 7 was not statistically significant. On day 14, there were fewer VEGF positive cells in group C than in group B (U=3.00, P<0.05). Conclusion Tacrolimus is effective for nonspecific keratitis induced by alkali burn and superior to dexamethasone for safety.

Key words： Dexamethasone Keratitis Eye burns Vascular endothelial growth factors Rats,Sprague-Dawley Tacrolimus

收稿日期: 2015-01-02

通讯作者: 李锦阳，Email：jinyangli@outlook.com

引用本文:

闫应朝,李锦阳,陈梦曦,徐思思,张一威,谷丽君. 他克莫司治疗碱烧伤致大鼠非特异性角膜炎的疗效及安全性[J]. 中华眼视光学与视觉科学杂志, 2016, 18(1): 33-40. Yan Yingzhao,Li Jinyang,Chen Mengxi,Xu Sisi,Zhang Yiwei,Gu Lijun. The efficacy and safety of tacrolimus for treating nonspecific keratitis in rats caused by alkali burn . Chinese Journal of Optometry Ophthalmology and Visual science, 2016, 18(1): 33-40. DOI: DOI:10.3760/cma.j.issn.1674-845X.2016.01.008

链接本文:

https://www.cjoovs.com/CN/DOI:10.3760/cma.j.issn.1674-845X.2016.01.008 或 https://www.cjoovs.com/CN/Y2016/V18/I1/33

[1]	王媛,周跃华. LASIK术后弥漫性板层角膜炎的发病机制及药物调控[J]. 眼科研究,2009,27(2):157-160. DOI:10.3760/cma.j.issn.2095-0160.2009.02.018.
[2]	许诗琼,贾仁兵,范先群,等. 婴幼儿眼部血管瘤治疗进展[J]. 中华眼视光学与视觉科学杂志,2013,15(10):637-640. DOI:10.3760/cma.j.issn.1674-845X.2013.10.015.
[3]	叶成添,林跃生,唐细兰,等. 他克莫司滴眼液与环孢素A滴眼液在全角膜移植术后免疫排斥反应的疗效观察[J]. 广东药学,2004,14(6):43-44. DOI:10.3969/j.issn.1674-229X.2004.06.021.
[4]	顾宏卫,胡楠. 大鼠角膜碱烧伤模型制备方法的研究[J]. 国际眼科杂志,2013,13(6):1093-1095. DOI:10.3980/j.issn.1672-5123. 2013.06.08.
[5]	Krachmer JH, Mannis MJ, Holland EJ. Alkali injuries of the eye[M]. Philadelphia: Elsevier Mosby,2005:1288.
[6]	Papathanassiou M, Theodossiadis PG, Liarakos VS, et al. Inhibition of corneal neovascularization by subconjunctival bevacizumab in an animal model[J]. Am J Ophthalmol,2008, 145(3):424-431. DOI:10.1016/j.ajo.2007.11.003.
[7]	Giacomini C, Ferrari G, Bignami F, et al. Alkali burn versus suture-induced corneal neovascularization inC57BL/6 mice: an overview of two common animal models of corneal neovascularization[J]. Exp Eye Res,2014,121:1-4. DOI:10.1016/j.exer.2014.02.005.
[8]	D′Amato RJ, Loughnan MS, Flynn E, et al. Thalidomide is an inhibitor of angiogenesis[J]. Proc Natl Acad Sci USA,1994, 91(9):4082-4085.
[9]	邱培瑾,姚克,朱丽君,等. 鼠角膜碱烧伤后血管内皮细胞生长因子在其角膜中的表达及意义[J]. 中华眼科杂志,2002,38(5):311-314. DOI:10.3760/j:issn:0412-4081.2002.05.018.
[10]	Wang JC, Su D, Lim L. Contact lens microbial keratitis and prior topical steroid use: a disaster in the making?[J]. Ann Acad Med Singapore,2004,33(4):484-488.
[11]	Stein RM, Clinch TE, Cohen EJ, et al. Infected vs sterile corneal infiltrates in contact lens wearers[J]. Am J Ophthalmol,1988,105(6):632-636.
[12]	Ben-Hanan I, Landshman N, Assia E, et al. Further evidence for the involvement of immunoregulatory processes in corneal alkali burns: effects of immunosuppression and convalescent serum[J]. Ophthalmic Res,1986,18(5):288-291.
[13]	幸正茂,刘菲,袁进. 角膜碱烧伤的免疫学机制研究进展[J]. 眼科研究,2010,28(8):796-799. DOI:10.3969/j.issn.1003-0808.2010.08. 028.
[14]	Sosne G, Christopherson PL, Barrett RP, et al. Thymosin-beta4 modulates corneal matrix metalloproteinase levels and polymorphonuclear cell infiltration after alkali injury[J]. Invest Ophthalmol Vis Sci,2005,46(7):2388-2395. DOI:10.1167/iovs.04-1368.
[15]	赵敏,陈家祺,杨培增. 鼠角膜碱烧伤的免疫学研究[J]. 中华眼科杂志,2000,36(1):40-42. DOI:10.3760/j:issn:0412-4081.2000.01.011.
[16]	Kao WW, Zhu G, Benza R, et al. Appearance of immune cells and expression of MHCⅡ DQ molecule by fibroblasts in alkali-burned corneas[J]. Cornea,1996,15(4):397-408. DOI:10.1097/00003226-199607000-00010.
[17]	Chang JH, Garg NK, Lunde E, et al. Corneal neovascularization: an anti-VEGF therapy review[J]. Surv Ophthalmol,2012,57(5):415-429. DOI:10.1016/j.survophthal.2012.01.007.
[18]	Lu P, Li L, Wu Y, et a1. Essential contribution of CCL3 to alkalj-induced corneal neovaseuIarization by regulating vascular endothelial growth factor production by macrophages[J]. Mol Vis, 2008,14:16l4-l622.
[19]	Spencer CM, Goa KL, Gillis JC. Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation[J]. Drugs,1997,54(6):925-975.
[20]	Vichyanond P, Kosrirukvongs P. Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis[J]. Curr Allergy Asthma Rep,2013,13(3):308-314. DOI:10.1007/s11882-013-0345-0.
[21]	Al-Amri AM. Long-term follow-up of tacrolimus ointment for treatment of atopic keratoconjunctivitis[J]. Am J Ophthalmol,2014,157(2):280-286. DOI:10.1016/j.ajo.2013.10.006.
[22]	邓宏伟,李辰. 角膜缘干细胞生存微环境的研究进展[J]. 中国实用眼科杂志,2002,20(6):403-406. DOI:10.3760/cma.j.issn.1006-4443.2002.06.001.
[23]	Hikita N, LoPez JS, Chan CC, et al. Use of topical FK506 in a corneal graft rejection model in Lewis rats[J]. Invest Ophthalmol Vis Sci,1997,38(5):901-909.
[24]	Namkoong S, Chung J, Yoo J, et al. Topical tacrolimus does not negatively impact acute skin wound healing[J]. Exp Dermatol,2013,22(5):369-371. DOI:10.1111/exd.12131.
[25]	唐宁,安晓,张莉. FK506与环孢霉素A对角膜损伤愈合的对比研究[J]. 眼科新进展,2004,24(4):278-279. DOI:10.3969/j.issn.1003-5141.2004.04.013.
[26]	Hoffart L, Matonti F, Conrath J, et al. Inhibition of corneal neovascularization after alkali burn: comparison of different doses of bevacizumab in monotherapy or associated with dexamethasone[J]. Clin Experiment Ophthalmol,2010,38(4):346-352.
[27]	孙亚杰,李爱朋,潘志强. 几种抗炎滴眼液对兔角膜上皮损伤和愈合影响的实验研究[J]. 眼科,2012,21(3):166-171.
[28]	Su W, Li Z, Li Y, et al. Doxycycline enhances the inhibitory effects of bevacizumab on corneal neovascularization and prevents its side effects[J]. Invest Ophthalmol Vis Sci,2011,52(12):9108-9115． DOI:10.1167/iovs.11-7255.
[29]	Luo JC, Shin VY, Liu ES, et al. Dexamethasone delays ulcer healing by inhibition of angiogenesis in rat stomachs[J]. Eur J Pharmacol,2004,485(1-3):275-281. DOI:10.1016/j.ejphar.2003.11. 038.
[30]	项俊,徐建江．难治性蚕食性角膜溃疡的新药物治疗[J]．中国眼耳鼻喉科杂志,2010,10(4):258-260． DOI:10.3969/j.issn.1671-2420. 2010.04.037.